Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,677,474
+$5,221,036 QoQ
Shares Held
783,873
+73.5% QoQ
Ownership
0.832%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#25
of 199 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Derivatives in REPL
reported options exposure · as of Jun 30, 2026CallValue
$32,687,496
CallShares
2,952,800
PutValue
$2,447,577
PutShares
221,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. REPL ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
This page
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in REPL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,677,474 | 783,873 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $2,447,577 | 221,100 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $32,687,496 | 2,952,800 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $612,000 | 80,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $3,456,438 | 451,822 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $6,828,390 | 892,600 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $2,221,700 | 228,570 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $826,200 | 85,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $8,748,000 | 900,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $712,300 | 170,000 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $3,570,718 | 852,200 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $4,139,624 | 445,600 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $7,361,396 | 792,400 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $243,750 | 25,000 | Call | Sole | 2025-05-15 | |
| 2023-09-30 | $11,290,889 | 659,900 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $3,849,750 | 225,000 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $783,022 | 45,764 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $765,516 | 32,968 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||